Login / Signup

Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial.

Naglaa Fathi AgamiaMarwa EssawyAmira Kassem
Published in: The Journal of dermatological treatment (2020)
Topical OXZ is a safe and effective treatment for post-acne erythema.
Keyphrases
  • hidradenitis suppurativa
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • double blind